Add Formweb to your mobile device
Search results for:
inFLIXimab
inFLIXimab
Brand names: Avsola, Inflectra, Remicade, Renflexis
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 100 mg; abda 100 mg; axxq 100 mg; dyyb 100 mg | Remicade 400169, Renflexis 600159, Inflectra 400496 - restricted SDSD |
VIEW MORE GI Drugs, Miscellaneous, Skin and Mucous Membrane Agents, Miscellaneous, Immunomodulatory Agents, Disease-Modifying Antirheumatic Drugs
CLASS
CLASS
569200, 849200, 922000, 923600
Last updated: Oct. 15, 2025
- Black Box Warning: Serious infection risk; hepatosplenic t-cell lymphomas; malignancy
- Therapeutic Interchange: Biosimilar and Reference Products Conversion List for Adults
- Do Not Tube-LALK
- Restricted: inFLIXimab is restricted to the Outpatient setting except for Inpatient use by gastroenterologists in patients with Crohn's disease or ulcerative colitis who are nearing obstruction
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments)
Biosimilar and Reference Products Interchange List for Adults
Medication
Reference Drug or Biosimilar
Formulary Status
Automatic Therapeutic Interchange
Inpatient1
Outpatient
*New Starts/New Authorizations Only*
Renflexis (infliximab-abda)
Biosimilar
Formulary
Use Renflexis
Interchange to generic infliximab unless third party payer requires other infliximab product
Inflectra (infliximab-dyyb)
Avsola (infliximab-axxq)
Biosimilars
Formulary, restricted to OP
(not preferred)
Interchange to Renflexis
Remicade (infliximab) brand
Reference
Generic infliximab
Reference generic
Formulary, restricted to OP
(preferred)
Use generic infliximab unless third party payer requires other infliximab product
Zymfentra SubQ will be formulary restricted to outpatient use only.
LALK Chemotherapy/Biologic Agents Restriction